Article Information
History
- August 18, 2022.
Article Versions
- Version 1 (August 10, 2022 - 21:18).
- Version 2 (August 12, 2022 - 07:34).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Mark Gormley, BDS*,1,2,
- Tom Dudding, PhD2,
- Steven J Thomas, PhD2,
- Jessica Tyrrell, PhD3,
- Andrew R Ness, PhD4,
- Miranda Pring, PhD2,
- Danny Legge, PhD5,
- George Davey Smith, FRS1,
- Rebecca C Richmond, PhD1,
- Emma E Vincent, PhD1,5,§ and
- Caroline Bull, PhD1,5,§
- 1MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
- 2Bristol Dental Hospital and School, University of Bristol, Bristol, UK
- 3University of Exeter Medical School, RILD Building, RD&E Hospital, Exeter, UK
- 4University Hospitals Bristol and Weston NHS Foundation Trust National Institute for Health Research Bristol Biomedical Research Centre, University of Bristol, Bristol, UK
- 5Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
- ↵*Corresponding author: mark.gormley{at}bristol.ac.uk
Posted August 18, 2022.
Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using Mendelian randomization
